KBC Group NV Has $14.45 Million Stock Position in Mettler-Toledo International Inc. (NYSE:MTD)

KBC Group NV lessened its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 2.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,811 shares of the medical instruments supplier’s stock after selling 242 shares during the quarter. KBC Group NV’s holdings in Mettler-Toledo International were worth $14,453,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in MTD. DT Investment Partners LLC raised its holdings in shares of Mettler-Toledo International by 13.3% during the third quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier’s stock worth $102,000 after acquiring an additional 8 shares during the period. UMB Bank n.a. lifted its holdings in shares of Mettler-Toledo International by 8.0% in the third quarter. UMB Bank n.a. now owns 122 shares of the medical instruments supplier’s stock valued at $183,000 after purchasing an additional 9 shares in the last quarter. Bleakley Financial Group LLC boosted its position in shares of Mettler-Toledo International by 1.2% during the third quarter. Bleakley Financial Group LLC now owns 757 shares of the medical instruments supplier’s stock worth $1,135,000 after buying an additional 9 shares during the period. Suncoast Equity Management grew its holdings in shares of Mettler-Toledo International by 2.0% during the third quarter. Suncoast Equity Management now owns 460 shares of the medical instruments supplier’s stock worth $690,000 after buying an additional 9 shares in the last quarter. Finally, Huntington National Bank raised its position in Mettler-Toledo International by 20.0% in the 3rd quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock valued at $81,000 after buying an additional 9 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Insider Buying and Selling

In other news, insider Gerry Keller sold 140 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the sale, the insider now owns 6 shares of the company’s stock, valued at approximately $7,524.54. The trade was a 95.89 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now directly owns 240 shares in the company, valued at approximately $314,820. This represents a 24.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by insiders.

Analysts Set New Price Targets

MTD has been the subject of several research reports. Stifel Nicolaus decreased their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research note on Monday, November 11th. Wells Fargo & Company decreased their target price on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research report on Monday, November 11th. Robert W. Baird cut their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research report on Monday, November 11th. Evercore ISI upgraded Mettler-Toledo International from an “in-line” rating to an “outperform” rating and raised their price objective for the company from $1,375.00 to $1,450.00 in a report on Thursday, January 2nd. Finally, Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and upped their target price for the stock from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $1,351.25.

Mettler-Toledo International Stock Down 1.1 %

NYSE:MTD opened at $1,338.58 on Thursday. Mettler-Toledo International Inc. has a 12-month low of $1,133.46 and a 12-month high of $1,546.93. The firm has a market capitalization of $28.24 billion, a price-to-earnings ratio of 36.09, a P/E/G ratio of 4.19 and a beta of 1.12. The stock’s 50 day moving average price is $1,257.26 and its two-hundred day moving average price is $1,343.51.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The business had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. Equities research analysts expect that Mettler-Toledo International Inc. will post 40.42 EPS for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.